Dimethyl fumarate promotes the degradation of HNF1B and suppresses the progression of clear cell renal cell carcinoma
Abstract Clear cell renal cell carcinoma (ccRCC) is the most lethal subtype of renal cancer, and its treatment options remain limited. Therefore, there is an urgent need to discover therapeutic agents for ccRCC treatment. Here, we demonstrate that dimethyl fumarate (DMF), an approved medication for...
Saved in:
Main Authors: | Yue Dai, Hongchen Li, Shiyin Fan, Kai Wang, Ziyi Cui, Xinyu Zhao, Xue Sun, Mingen Lin, Jiaxi Li, Yi Gao, Ziyin Tian, Hui Yang, Bingbing Zha, Lei Lv, Yanping Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-025-07412-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma
by: Dinh-Xuan Pham, et al.
Published: (2025-02-01) -
Single cell suppression profiling of human regulatory T cells
by: Jonas Nørskov Søndergaard, et al.
Published: (2025-02-01) -
Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts
by: Joseph J. Caumanns, et al.
Published: (2025-02-01) -
Role of HNF6 in liver homeostasis and pathophysiology
by: Miaomiao Tian, et al.
Published: (2025-02-01) -
Infiltration of CD8+ cytotoxic T-cells and expression of PD-1 and PD-L1 in ovarian clear cell carcinoma
by: Mengdi Fu, et al.
Published: (2025-02-01)